Publications by authors named "Anna Platek"

Claim this Profile
M
Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor.
Anna E Platek, Anna Szymanska

Clin Exp Hepatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease.
Anna E Płatek, Julia A Szymańska

Prz Gastroenterol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot.
Filip M Szymański, Agnieszka Mickiewicz, Grzegorz Dzida, Iwona Gorczyca-Głowacka, Dariusz Kozłowski

Cardiol J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between air pollution and COVID-19 mortality and morbidity.
Karolina Semczuk-Kaczmarek, Anna Rys-Czaporowska, Janusz Sierdzinski, Lukasz Dominik Kaczmarek, Filip Marcin Szymanski, Anna Edyta Platek

Intern Emerg Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple embolic events and ruption of the central venous catheter in a patient with atrial fibrillation.
Tomasz Ostrowski, Karolina Semczuk-Kaczmarek, Rafał Maciąg, Anna E Płatek, Zbigniew Gałązka

Cardiol J· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of lower urinary tract symptoms in patients with cardiovascular disease.
Karolina Semczuk-Kaczmarek, Anna Rys-Czaporowska, Anna E Platek, Filip M Szymanski

Cent European J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myocardial Infarction Due to Antiphospholipid Syndrome - Case Report and Review of the Literature.
Karolina Semczuk-Kaczmarek, Anna E Platek, Anna Ryś-Czaporowska, Filip M Szymanski, Krzysztof J Filipiak

Curr Probl Cardiol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of obstructive sleep apnea in patients with peripheral arterial diseases.
Filip M Szymanski, Dariusz Gorko, Anna E Platek, Tomasz Ostrowski, Krzysztof Celejewski

Sleep Breath· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visfatin as a predictor of obstructive sleep apnea in atrial fibrillation patients.
Anna Szymanska, Anna E Platek, Janusz Sierdzinski, Filip M Szymanski

Sleep Breath· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will the COVID-19 Pandemic Change National Security and Healthcare in the Spectrum of Cardiovascular Disease?
Filip M Szymanski, Cezary Smuniewski, Anna E Platek

Curr Probl Cardiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute limb ischemia due to intracardiac myxoma in a patient with atrial fibrillation.
Anna Szymanska, Joanna Syska-Suminska, Jerzy Rekosz, Anna Skrobisz, Anna E Platek

Cardiol J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the 2MACE score as a predictor of long-term all-cause mortality in patients with atrial fibrillation.
Anna Szymańska, Anna E Płatek, Karolina Semczuk-Kaczmarek, Filip M Szymański, Mirosław Dłużniewski

Pol Arch Intern Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can adipokine visfatin be a novel marker of pregnancy-related disorders in women with obesity?
Anna Wnuk, Aleksandra Stangret, Mateusz Wątroba, Anna E Płatek, Marta Skoda

Obes Rev· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of Lyme Disease as a Predictor of Atrial Fibrillation.
Anna Szymanska, Anna E Platek, Miroslaw Dluzniewski, Filip M Szymanski

Am J Cardiol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-treatment of lower urinary tract symptoms and cardiovascular disease - where do we stand?
Karolina Semczuk-Kaczmarek, Anna E Płatek, Filip M Szymański

Cent European J Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of Visfatin as a Predictor of Atrial Fibrillation Recurrence After Ablation Procedure.
Anna E Platek, Anna Szymanska, Ilona Kalaszczynska, Filip M Szymanski, Janusz Sierdzinski

Am J Cardiol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
Karolina Semczuk-Kaczmarek, Anna E Płatek, Anna Ryś, Jakub Adamowicz, Paweł Legosz

Adv Clin Exp Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
Filip M Szymański, Marcin Barylski, Barbara Cybulska, Beata Wożakowska-Kapłon, Zbigniew Krasiński

Cardiol J· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlations between Vancouver type of periprosthetic femur fracture and treatment outcomes.
Pawel Legosz, Anna E Platek, Anna Rys-Czaporowska, Filip M Szymanski, Pawel Maldyk

J Orthop· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the prevalence of periodontal disease as a non-classical risk factor in the group of patients undergoing hip and/or knee arthroplasty.
Karolina Adamkiewicz, Anna E Płatek, Paweł Łęgosz, Maciej R Czerniuk, Paweł Małdyk

Kardiol Pol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilisation of lipid-lowering therapies in outpatient settings in Poland: epidemiological survey Economedica Dyslipidaemia 2015.
Filip M Szymański, Anna E Płatek, Anna Ryś, Karolina Semczuk-Kaczmarek, Bartosz Krzowski

Kardiol Pol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety of novel non-small cell lung cancer oncotherapy in a patient treated with novel generations of tyrosine kinase inhibitors.
Filip M Szymański, Anna E Płatek, Rafał Dziadziuszko, Paweł Łęgosz, Piotr Palczewski

Kardiol Pol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant small-cell neuroendocrine carcinoma infiltrating the heart.
Anna E Płatek, Robert Kowalik, Filip M Szymanski, Krzysztof J Filipiak

Kardiol Pol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Appropriate Non-Antiarrhythmic Pharmacotherapy in Atrial Fibrillation Patients with Rhythm Control Strategy.
Anna E Platek, Anna Hrynkiewicz-Szymanska, Anna Rys, Karolina Semczuk, Filip M Szymanski

Eur Cardiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choice of Anticoagulation Therapy in Atrial Patients with Rate Control and Rhythm Control Strategy - Data from a Multicenter Real-life Registry.
Anna E Platek, Anna Hrynkiewicz-Szymanska, Anna Rys, Karolina Semczuk, Filip M Szymanski

Eur Cardiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis